Thalamic atrophy is a potential biomarker for multiple sclerosis

被引：0
作者：
Mansbridge, Michael
机构：
来源：
NEURODEGENERATIVE DISEASE MANAGEMENT | 2013年 / 3卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [21] Effect of Ocrelizumab on Thalamic Atrophy in Patients with Relapsing and Primary Progressive Multiple Sclerosis
    Arnold, Douglas L.
    Sprenger, Till
    Bar-Or, Amit
    Wolinsky, Jerry S.
    Kappos, Ludwig
    Kolind, Shannon
    Manfrini, Marianna
    Magon, Stefano
    van Beek, Johan
    Koendgen, Harold
    Bernasconi, Corrado
    Gaetano, Laura
    Traboulsee, Anthony
    NEUROLOGY, 2020, 94 (15)
  • [22] Pattern of thalamic nuclei atrophy in early relapse-onset multiple sclerosis
    Levy, Sarah
    Sandry, Joshua
    Beck, Erin S.
    Brandstadter, Rachel
    Sand, Ilana Katz
    Sumowski, James F.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 67
  • [23] Endocan, novel potential biomarker for multiple sclerosis?
    Akil, E.
    Alp, R.
    Ozdemir, H. H.
    Arslan, D.
    Cevik, M. U.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 192 - 192
  • [24] Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis
    Leurs, C. E.
    Pinheiro, M. A. Lopes
    Wierts, L.
    den Hoedt, S.
    Mulder, M. T.
    Eijlers, A. J. C.
    Schoonheim, M. M.
    Balk, L. J.
    Uitdehaag, B. M. J.
    Killestein, J.
    de Vries, H. E.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 : 44 - 49
  • [25] The potential of serum neurofilament as biomarker for multiple sclerosis
    Bittner, Stefan
    Oh, Jiwon
    Havrdova, Eva Kubala
    Tintore, Mar
    Zipp, Frauke
    BRAIN, 2021, 144 : 2954 - 2963
  • [26] Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis
    Hanninen, Katariina
    Viitala, Matias
    Paavilainen, Teemu
    Karhu, Jari O.
    Rinne, Juha
    Koikkalainen, Juha
    Lotjonen, Jyrki
    Soilu-Hanninen, Merja
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [27] Clinical Disability Worsening Correlates Preferentially with Atrophy of Thalamic Subregions in Patients with Multiple Sclerosis
    Mahajan, Kedar
    Nakamura, Kunio
    Ontaneda, Daniel
    NEUROLOGY, 2020, 94 (15)
  • [28] Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease
    Azevedo, Christina J.
    Cen, Steven Y.
    Khadka, Sankalpa
    Liu, Shuang
    Kornak, John
    Shi, Yonggang
    Zheng, Ling
    Hauser, Stephen L.
    Pelletier, Daniel
    ANNALS OF NEUROLOGY, 2018, 83 (02) : 223 - 234
  • [29] Thalamic atrophy in Multiple Sclerosis is associated with higher serum GFAP levels and vascular dysfunction
    Fernandes, Catarina
    Pires, Ricardo
    Sousa, Joao
    Santos, Irina
    Machado, Rita Brito
    Nunes, Carla
    Correia, Ines
    Macario, Maria do Carmo
    Sousa, Livia Maria
    Baldeiras, Ines
    Pereira, Daniela
    Jacinto Santana, Maria Isabel
    Freitas, Joao Sargento
    Batista, Sonia
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 525 - 526
  • [30] Cortical lesions on double inversion recovery are associated with thalamic atrophy and disability in multiple sclerosis
    Kalinin, I.
    Makshakov, G.
    Shumilina, M.
    Evdoshenko, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 663 - 663
12345